DUBLIN, May 29, 2024 /PRNewswire/ Jazz Pharmaceuticals plc (Nasdaq: JAZZ) today announced that Company management will participate in the following investor conferences: Jefferies Global
SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, May 29, 2024 ORIC Pharmaceuticals, Inc. , a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic.
BURLINGTON, Mass., May 29, 2024 scPharmaceuticals Inc. , a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused.
Regulatory News: Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) ("Innate" or the "Company") today announced members of its executive team are scheduled to participate in the upcoming conferences
VANCOUVER, British Columbia, May 28, 2024 Zymeworks Inc. , a clinical-stage biotechnology company developing a diverse pipeline of novel, multifunctional biotherapeutics to improve the standard.